Table of contents

• Uterine Fibroids Treatment at a Glance
• What Is Uterine Fibroids Treatment?
• Who Is a Good Candidate for Uterine Fibroids Treatment?
• How Is Uterine Fibroids Treatment Performed?
• Why Visit Korea for Uterine Fibroids Treatment?
• Key Information for International Patients
• Which Are the Best Clinics in Korea for Uterine Fibroids Treatment?
• Uterine Fibroids Treatment From Start to Finish
• Alternatives to Uterine Fibroids Treatment
• How Can I Prepare for Uterine Fibroids Treatment?
• Aftercare Advice

Considering treatment in Korea? Everything you need to know e.g. — how to avoid scams, visas, interpreters, recovery tips — in our Medical Tourism Master Guide. Plan with confidence in minutes, not weeks!

Last updated: September 2026

Uterine Fibroids Treatment at a Glance

• Treatment options — Care ranges from bleeding-control medication and IUDs to hysteroscopic or abdominal myomectomy, uterine artery embolization (UAE), HIFU/RFA ablation, and hysterectomy; the best route depends on fibroid map, symptoms, and pregnancy goals.
• Best candidates — Treatment is typically considered for heavy bleeding causing anemia, significant pelvic pressure or pain, urinary or bowel symptoms, or cavity-distorting fibroids affecting fertility; small symptom-free fibroids can often be monitored.
• Fertility priority — For people pursuing pregnancy, myomectomy is the main uterus-preserving surgical option, especially for submucosal or cavity-distorting intramural fibroids; fertility outcomes after UAE, HIFU, and RFA remain less certain.
• Recovery range — Typical recovery is about 1 week after hysteroscopic myomectomy, 1–2 weeks after UAE, 4–6 weeks after laparoscopic or robotic myomectomy, and 6–8 weeks after open myomectomy or hysterectomy.
• When results appear — Myomectomy removes targeted fibroids immediately, while UAE, HIFU/MRgFUS, and RFA shrink treated fibroids gradually over months; UAE-related shrinkage may continue for a year or longer.
• Korea travel planning — Plan roughly 3–5 days in Korea after an uncomplicated hysteroscopic procedure, UAE, or focused ultrasound, and at least 10–14 days after laparoscopic or robotic myomectomy; written surgeon clearance is required before a long-haul flight.
• Korea-specific distinction — Korean centers have published HIFU experience in a 618-patient single-center series and robotic myomectomy series, showing local availability and expertise but not proving either platform is superior for every fibroid pattern.

What Is Uterine Fibroids Treatment?

Uterine fibroids treatment is a personalized range of options that manages benign growths in or on the uterus, from medication to procedures or surgery. It aims to reduce heavy bleeding, anemia, pelvic pressure, pain, and fertility concerns while reflecting goals for uterine preservation or definitive relief. Treatment can be non-surgical, minimally invasive, or surgical, depending on the selected approach.

Who Is a Good Candidate for Uterine Fibroids Treatment?

• Disruptive bleeding or anemia — Candidates have heavy or prolonged periods that interfere with daily life, cause iron-deficiency anemia, or remain troublesome despite medical treatment.
• Pressure symptoms — Pelvic heaviness, urinary frequency, constipation, abdominal enlargement, pain, or pain during sex can justify treatment when imaging confirms that fibroids are the likely cause.
• Fertility-focused care — People pursuing pregnancy with a submucosal fibroid or an intramural fibroid that distorts the uterine cavity often need specialist review. Myomectomy is the principal uterus-preserving surgical option in this setting.
• Need for durable control — Candidates may prioritize keeping the uterus, avoiding major surgery, treating several fibroids at once, or definitively preventing fibroid recurrence.

Treatment is not required for every fibroid: observation is often appropriate for small, symptom-free fibroids, particularly near menopause, as outlined by ACOG. Pregnancy must be excluded before an intervention where relevant, and treatment is generally deferred during pregnancy. Active pelvic infection, untreated severe illness, unstable bleeding, or significant anemia require treatment and optimization first. Rapid growth after menopause, atypical imaging, or uncertainty about the diagnosis requires evaluation before elective treatment; imaging alone cannot exclude every uterine malignancy. The choice also depends on FIGO location, number and size of fibroids, cavity distortion, prior surgery, and whether future pregnancy is important.

How Is Uterine Fibroids Treatment Performed?

Fibroid treatment ranges from symptom control to uterus-preserving procedures and definitive hysterectomy. The appropriate route follows the fibroid map, symptoms, medical history, anesthesia suitability, and reproductive goals—not a preference for one device or surgical platform.

• Observation and medication — NSAIDs treat menstrual pain; tranexamic acid reduces menstrual blood loss but does not shrink fibroids. Hormonal contraception, progestins, and a levonorgestrel IUD can reduce bleeding when the uterine cavity is suitable. GnRH agonists or GnRH antagonist treatment with add-back hormones can temporarily control bleeding or reduce fibroid size, often before surgery; symptoms and growth can return after treatment stops.
• Hysteroscopic myomectomy — A surgeon passes a hysteroscope through the vagina and cervix to remove selected submucosal fibroids without abdominal incisions. This route targets heavy bleeding and cavity distortion. Large or deeply embedded lesions can require staged treatment or a different approach.
• Laparoscopic, robotic, or open myomectomy — Myomectomy removes fibroids while preserving the uterus. Laparoscopic and robotic procedures use small abdominal incisions, while open abdominal surgery can be appropriate for very large, numerous, or deeply embedded fibroids. Robotic assistance is a surgical platform, not a distinct biological treatment, and is not automatically superior.
• Uterine artery embolization (UAE/UFE) — An interventional radiologist passes a catheter through an artery, usually at the wrist or groin, then injects particles to reduce fibroid blood flow. UAE can treat multiple fibroids while retaining the uterus, but it does not remove them; pain, post-embolization symptoms, infection, incomplete response, and later reintervention require discussion. Future-pregnancy effects remain unclear.
• Focused ultrasound and radiofrequency ablation — MRI-guided or ultrasound-guided HIFU/MRgFUS heats selected fibroid tissue without removing it. RFA heats fibroids through a laparoscopic, transcervical, transvaginal, or platform-specific route. Eligibility depends heavily on fibroid access, bowel and scar position, imaging features, and device availability; shrinkage occurs gradually over months.
• Hysterectomy — Removal of the uterus permanently ends periods and prevents uterine fibroids from recurring. It also permanently ends the ability to carry a pregnancy; keeping or removing the ovaries is a separate decision.

Why Visit Korea for Uterine Fibroids Treatment?

South Korea has published clinical experience with HIFU and robotic myomectomy, so these approaches are performed in the country. That evidence does not establish that a specific Korean platform is superior for every patient. Overseas patients need a hospital that reviews the actual ultrasound or MRI rather than assigning a treatment from symptoms alone.

• Documented HIFU experience — A Korean single-center report evaluated 618 HIFU-treated patients and described encouraging short- and medium-term findings, while also calling for well-designed prospective trials. This supports availability and experience, not guaranteed superiority or suitability for all fibroid patterns, as shown in the published Korean report.
• Published robotic-myomectomy cohorts — Seoul-based publications include retrospective single-center robotic single-site myomectomy series of 61 and 101 selected cases. These data support technical feasibility, but they do not prove that robotic surgery is preferable to conventional laparoscopy or open surgery for an individual patient, as reflected in this Korean cohort publication.
• Imaging-led treatment planning — Ultrasound is useful for initial assessment, while MRI can map fibroid number, location, vascularity, degeneration, and coexisting adenomyosis for complex myomectomy, embolization, or ablation planning. The American College of Radiology guidance supports this role for imaging, while noting that MRI cannot reliably exclude every uterine sarcoma.
• Ask about the complete pathway — Confirm access to gynecologic surgery, interventional radiology, anesthesia, pathology, transfusion support, fertility input, English documentation, and overseas follow-up. Availability of a particular HIFU unit, RFA route, embolic particle, robotic system, or English-language service varies by hospital.

Key Information for International Patients

• Minimum stay — There is no universal safe stay in Korea. As a planning range rather than a flight-clearance rule, allow about 3–5 days after an uncomplicated hysteroscopic procedure, UAE, or focused-ultrasound treatment with satisfactory early review; plan at least 10–14 days after laparoscopic or robotic myomectomy.
• Major-surgery planning — Open myomectomy and hysterectomy commonly need 6–8 weeks of recovery and are poor fits for a short medical-tourism trip. Arrange a longer local recovery period or defer travel until recovery can be managed safely at home.
• Flight clearance — Do not book a long-haul return flight until the operating team gives written approval. Clearance depends on bleeding, pain control, sedating medicines, mobility, postoperative review, complications, and personal venous-thromboembolism risk.
• Companion and transport — Arrange a companion after general anesthesia, IV sedation, UAE with substantial pain-control needs, and inpatient surgery. Do not drive or stay alone when the facility’s discharge policy requires observation.
• Itinerary impact — Hysteroscopy is commonly a day procedure, while UAE often involves outpatient care or one overnight stay. Laparoscopic, robotic, open myomectomy, and hysterectomy require a recovery-focused itinerary rather than sightseeing.
• Records and remote follow-up — Before departure, obtain an English discharge summary, operative and anesthesia records, medication list, imaging, pathology when available, and a written escalation plan. Arrange a local gynecology, primary-care, and fertility follow-up clinician before leaving home.

Travel note: For long-haul travel after pelvic surgery, discuss individualized clot-prevention measures. Walking, hydration, and leg exercises are common measures; use compression or anticoagulants only when prescribed. Seek urgent help for one-sided calf pain or swelling, chest pain, or shortness of breath.

Which Are the Best Clinics in Korea for Uterine Fibroids Treatment?

Listed below are some of the best clinics in Korea for uterine fibroids treatment.

1. Seoul Miz Promise IVF

If uterine fibroids are affecting your fertility plans or reproductive health, Seoul Miz Promise IVF may be a clinic to consider when discussing how fibroid care could fit with your goals.

• URL: Seoul Miz Promise IVF Website
• Location: Seoul

2. SH Clinic

At SH Clinic, you can seek gynecologic care from a clinic focused on women’s health, with procedures performed directly by an experienced board-certified gynecologist. As the supplied information does not specify a fibroid-treatment technique, you should clarify which assessment and treatment options are appropriate for your symptoms and goals.

• URL: SH Clinic Website
• Location: Seocho-gu, Seoul
• Gynecologic care:
  • The clinic provides general gynecological care alongside services for cervical and ovarian cancer screening and urinary incontinence.
  • Women’s health services are delivered in a clinic designed to support comfort and specialized care for female patients.
• Clinician information: Surgeries and procedures are performed directly by a board-certified gynecologist who has received a commendation from the Minister of Health and Welfare.

3. Cheongdam HIFU Clinic

Cheongdam HIFU Clinic offers uterine-fibroid treatment options ranging from non-surgical HIFU ablation to minimally invasive and robotic surgery, allowing your approach to be matched to the fibroid’s characteristics and your wish to preserve your uterus when possible.

• URL: Cheongdam HIFU Clinic Website
• Location: Gangnam-gu, Seoul
• Non-surgical fibroid option:
  • HIFU uses focused ultrasound to ablate fibroid tissue without invasive surgery.
  • This approach is presented as an option for reducing fibroid-related symptoms while preserving the uterus.
• Surgical options:
  • Laparoscopic surgery uses small incisions and camera guidance for fibroid removal, with generally faster recovery and less postoperative pain than traditional surgery.
  • Da Vinci robotic surgery may be used for complex gynecologic procedures, including myomectomy or hysterectomy, with enhanced surgical precision and minimal incisions.
  • Hysteroscopic surgery can diagnose and treat fibroids located inside the uterus through the vagina and cervix, typically with a quick recovery.
• Related gynecologic care:
  • The clinic also treats adenomyosis with HIFU and provides care for ovarian cysts and endometriosis, including sclerotherapy options.
  • Its gynecology service is structured around one-stop diagnosis and treatment for uterine and ovarian conditions.

Uterine Fibroids Treatment From Start to Finish

1. Remote consultation and records review — Send symptom history, menstrual and pregnancy status, fertility goals, ultrasound or MRI files and reports, prior operative or pathology reports, CBC and ferritin results, medication and allergy lists, and anticoagulant history. Confirm whether English or virtual consultation is available.
2. Treatment planning before travel — The clinician reviews fibroid number, size, FIGO location, cavity distortion, anemia, possible adenomyosis, and reproductive priorities. Ask for the proposed route, anesthesia plan, expected admission, pathology and morcellation plan, chance of staged treatment or conversion to open surgery, and written travel-clearance criteria.
3. In-person assessment and tests — Assessment can include a pelvic examination, transvaginal and transabdominal ultrasound, pregnancy test when relevant, CBC and iron testing, and MRI for complex mapping. MRI is particularly useful for planning uterus-preserving treatment, embolization, or ablation, as described in ACR imaging guidance.
4. Final shared decision — Confirm whether the priority is bleeding control, pressure relief, restoring the uterine cavity, uterine preservation, conception, or definitive treatment. Discuss risks including hemorrhage, transfusion, adhesions, infection, injury to nearby organs, thromboembolism, recurrence, and reintervention.
5. Treatment day — Hysteroscopic myomectomy is commonly outpatient. UAE generally uses local anesthesia with sedation. Laparoscopic, robotic, and open myomectomy, as well as hysterectomy, usually require general anesthesia. Removed fibroid tissue should undergo pathology review.
6. Discharge and early review — Discharge follows stable vital signs, controlled pain and nausea, safe walking, urination, oral intake, and an appropriate support plan. Attend the early review before any planned flight.
7. Recovery and overseas follow-up — Hysteroscopic cramping often lasts several days; normal activity often resumes in about one week, while bleeding or discharge can last 3–4 weeks. UAE recovery commonly takes 1–2 weeks; laparoscopic or robotic myomectomy commonly takes 4–6 weeks, sometimes 6–8 weeks; open surgery commonly takes 6–8 weeks. Send postoperative records to the local clinician and complete remote review for symptoms, wounds, pathology, imaging, and fertility planning.

Alternatives to Uterine Fibroids Treatment

The main tradeoff is between symptom control, uterine preservation, future-pregnancy considerations, recovery burden, and definitive prevention of recurrence. No method is best for every fibroid pattern, and fertility evidence is especially limited after UAE, HIFU/MRgFUS, and RFA.

Medication and IUD

• Best role — Medication can control bleeding or period pain without removing fibroids. Tranexamic acid reduces blood loss; GnRH therapies can provide temporary bleeding control or shrinkage; hormonal treatment can help selected patients.
• IUD limitation — A levonorgestrel IUD can reduce bleeding only when cavity distortion does not prevent placement or effectiveness. See levonorgestrel IUD treatment.
• Tradeoff — Fibroids remain in place, and symptoms or growth can return after medication stops.

Uterine Artery Embolization

• Best role — UAE treats several fibroids in one session while retaining the uterus and avoiding fibroid-removal surgery.
• Tradeoff — Fibroids shrink rather than being removed, post-procedure cramping can be substantial, and the effect on future pregnancy is uncertain according to ACOG.

Focused Ultrasound or RFA

• Best role — These uterus-preserving ablation methods can suit selected accessible fibroids when a less invasive approach is a priority.
• Tradeoff — Anatomy and technology access determine candidacy; treated tissue changes gradually, and evidence for later pregnancy remains limited. ACOG notes that more research is needed on RFA and future pregnancy.

Hysterectomy

• Best role — Hysterectomy is definitive treatment for people who do not want future pregnancy and want to eliminate menstrual bleeding and fibroid recurrence.
• Tradeoff — It is major surgery and permanently ends the ability to carry a pregnancy. Learn more about hysterectomy.

How Can I Prepare for Uterine Fibroids Treatment?

• Send records early — Provide ultrasound and MRI images, reports, CBC and ferritin results, fertility records, prior surgical or pathology reports, and a complete medication and allergy list before travel.
• Disclose bleeding-risk medicines — Report warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel, aspirin, NSAIDs, insulin, diabetes medicines, blood-pressure medicines, hormones, and iron. Also disclose fish oil, vitamin E, ginkgo, garlic, ginseng, turmeric/curcumin, St John’s wort, and all herbal products. Do not stop prescribed medicine unless the responsible clinician gives a specific plan.
• Correct anemia — Ask whether oral or IV iron, bleeding-control medication, GnRH treatment, or a transfusion plan is needed before intervention. Significant anemia increases procedural and travel risk.
• Exclude pregnancy and infection — Complete pregnancy testing where relevant and report fever, unusual discharge, pelvic infection symptoms, or a new positive pregnancy test immediately.
• Follow fasting instructions — Follow the facility’s exact food, clear-fluid, and medication instructions for anesthesia or sedation. These differ by procedure and medical history.
• Stop smoking and limit alcohol — Stop smoking or vaping as far in advance as possible and follow the hospital’s alcohol restriction before anesthesia and surgery.
• Plan recovery logistics — Book accommodation with minimal stairs, reliable access to urgent care, and enough time for early review. Arrange a companion and private ground transport after sedation or general anesthesia.

Travel note: Keep return flights flexible until the team confirms the procedure route and reviews early recovery. A planned minimally invasive procedure can require a different course if anatomy, bleeding, or complications demand it.

Confirm the treating doctor’s individualized medication, fasting, anemia-management, and travel requirements; they take precedence over general guidance.

Aftercare Advice

Recovery after fibroid treatment requires active monitoring because bleeding, pain, mobility limits, and travel readiness differ sharply by treatment route.

• Use pain medicine safely — Take prescribed pain and anti-nausea medicines exactly as directed. UAE often causes significant cramping in the first days; contact the treating team when pain escalates rather than adding unapproved medicines.
• Move, hydrate, and protect bowel function — Walk regularly as permitted, perform leg exercises, drink fluids, eat fiber, and use a clinician-approved bowel regimen when opioid pain medicines or surgery cause constipation.
• Respect route-specific restrictions — Avoid heavy lifting, strenuous exercise, driving, penetrative sex, tampons, baths, and swimming until the treating team permits them. Restrictions depend on hysteroscopy, embolization, ablation, laparoscopic surgery, or open surgery.
• Care for incisions — Follow the hospital’s instructions for showering, dressings, and wound checks after laparoscopic, robotic, or open surgery. Once fully healed, protect scars with SPF 50 sunscreen to reduce discoloration.
• Know urgent warning signs — Seek urgent care for soaking a pad in an hour, severe or worsening pelvic pain, fever or chills, persistent vomiting, fainting, abdominal swelling, foul-smelling discharge, wound redness or drainage, inability to urinate, calf pain or swelling, chest pain, or shortness of breath. After UAE, fever above 101°F/38.3°C warrants prompt contact with the treating team, according to ACOG guidance.
• Allow time for results — Myomectomy removes targeted fibroids immediately, though new fibroids can develop later. UAE, HIFU/MRgFUS, and RFA produce gradual shrinkage and symptom change over months; shrinkage after UAE can continue for a year or longer. The safe interval before trying to conceive must be individualized.

Follow the treating doctor’s instructions and contact the clinic promptly when bleeding, pain, fever, discharge, urinary symptoms, or wound appearance seems wrong.